August 16, 2016

Tempe, AZ

Biosensing Instrument Inc (BI) announced today that the BI-4500 has been named finalist for the prestigious R&D 100 Award in the Analytical/Test category.

“We are excited to be among the innovative leaders,” said Dr. Nguyen Ly, Director of Research and Development of BI.   “Our BI-4500 enables scientists to generate highest quality results at a higher throughput per experimental assay and its open architecture expands traditional SPR application frontiers by combining SPR technology with electrochemistry or chemical vapor sensing. We are honored that our innovations have been recognized.”

The BI-4500 is a 5-Channel Label Free Surface Plasmon Resonance System used in the life science basic and applied life research to study the interactions between molecules in real time without the aid of fluorescent labels. The systems are utilized to measure biomolecular kinetics, molecular adsorption, concentration of biomolecules, and strength of molecular interactions.

Widely recognized as the “Oscars of Innovation”, the R&D 100 Awards identify and celebrate the top technology products of the year. Past winners have included sophisticated testing equipment, innovative new materials, high-energy physics, biomedical products, software and biotechnology. The winners of the 2016 R&D 100 Awards will be announced at the annual gala to be held on November 3rd.


About Biosensing Instrument

Biosensing Instrument, Inc. (BI) is a privately held company based in Tempe, Arizona and a technology leader in label-free molecular interaction analysis applications. The BI solutions are based on the Surface Plasmon Resonance (SPR) technology and the instruments are high performance, modular and cost-effective. They are used in academic and biopharmaceutical research for the measurement of affinity and kinetics of small or large biomolecules. Application areas include life sciences, drug discovery, antibody characterization, biosensors and electrochemistry. Information about BI can be found at